Anti-VEGF Therapeutics Market To Touch $13,812.6 Million Revenue by 2030, says P&S Intelligence
NEW YORK, June 14, 2022 /PRNewswire/ -- According to the recent market research study published by P&S Intelligence, the revenue of the anti-VEGF therapeutics market will increase from $12,178.0